Immunocore Holdings PLC
IMCR
ISIN null / Valor 59524572
Immunocore Holdings PLC
UMushroom community rating:
About company
Immunocore Holdings PLC is a commercial-stage biotechnology company focused on developing T cell receptor (TCR) therapies to address a range of medical conditions. Utilizing a modular platform, Immunocore creates ImmTAC therapies to enhance the immune system's ability to combat cancer, ImmTAV therapies targeting infectious diseases, and ImmTAAI therapies designed to regulate the immune response in autoimmune disorders. Notably, the company pioneered the discovery and commercialization of the first approved TCR therapy, establishing itself as a leader in the immunotherapy sector.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
1428 M
Market cap (USD)
509,839
Daily traded volume (Shares)
29.25 / 28.38
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Harith Damiel
EQUITIES OF THE SAME SECTOR
